BERGEN BRUNSWIG CORP
8-K, 1998-03-18
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: BASE TEN SYSTEMS INC, DEF 14A, 1998-03-18
Next: BOND FUND OF AMERICA INC, 497, 1998-03-18



                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549



                               ------------------







                                    FORM 8-K


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934




        Date of Report (Date of earliest event reported): March 16, 1998





                           BERGEN BRUNSWIG CORPORATION
               (Exact Name of Registrant as Specified in Charter)



New Jersey                         1-5110                        22-1444512
(State Or Other                   (Commission                  (IRS Employer
Jurisdiction Of                   File Number)              Identification No.)
Incorporation)




       4000 Metropolitan Drive, Orange, California                    92668
  --------------------------------------------------------------------------
               (Address of Principal Executive Offices)          (Zip Code)







       Registrant's telephone number, including area code (714) 385-4000





<PAGE>


Item 5.  Other Events.

     On March 16, 1998, Bergen Brunswig  Corporation,  a New Jersey  corporation
("Bergen"),  Cardinal Health, Inc., an Ohio corporation ("Cardinal"),  and Bruin
Merger Corp., a New Jersey corporation and a wholly owned subsidiary of Cardinal
("Subcorp"),  entered into the First  Amendment (the "First  Amendment to Merger
Agreement") to Agreement and Plan of Merger, dated as of August 23, 1997, by and
among Cardinal, Subcorp and Bergen (prior to any amendment, the "Original Merger
Agreement"). The First Amendment to Merger Agreement, among other things, amends
certain of the  termination  provisions of the Original  Merger  Agreement.  The
First  Amendment  to Merger  Agreement  is filed as Exhibit  99.1  hereto and is
incorporated  herein  by  reference.  The  foregoing  description  of the  First
Amendment to Merger  Agreement is qualified in its entirety by reference to such
Exhibit.


Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.


     (c) Exhibits.


     The following exhibit is filed as part of this report:




99.1 First  Amendment  to Agreement  and Plan of Merger,  dated as of August 23,
     1997, by and among  Cardinal  Health,  Inc.,  Bruin Merger Corp. and Bergen
     Brunswig Corporation, made as of March 16, 1998



<PAGE>


                                    SIGNATURE



     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                       BERGEN BRUNSWIG CORPORATION



Date:  March 17, 1998
                                        By:    /s/ Milan A. Sawdei
                                               ____________________________
                                               Milan A. Sawdei
                                               Executive Vice President
                                               Chief Legal Officer and Secretary



<PAGE>


                                  EXHIBIT INDEX



Exhibit
Number            Description


99.1 First  Amendment  to Agreement  and Plan of Merger,  dated as of August 23,
     1997, by and among  Cardinal  Health,  Inc.,  Bruin Merger Corp. and Bergen
     Brunswig Corporation, made as of March 16, 1998






                               FIRST AMENDMENT TO

                          AGREEMENT AND PLAN OF MERGER

     This  First  Amendment  (this  "Amendment")  to the  Agreement  and Plan of
Merger,  dated as of August  23,  1997 (the  "Merger  Agreement"),  by and among
Cardinal Health, Inc., an Ohio corporation  ("Cardinal"),  Bruin Merger Corp., a
New Jersey  corporation and a wholly owned  subsidiary of Cardinal  ("Subcorp"),
and Bergen Brunswig Corporation, a New Jersey corporation ("Bergen"), is made as
of March 16, 1998.

                                R E C I T A L S:

     WHEREAS,  Cardinal, Subcorp and Bergen are parties to the Merger Agreement,
providing  for the merger of Subcorp  with and into  Bergen,  with Bergen as the
surviving corporation (the "Merger"); and

     WHEREAS,  the  parties  desire to amend the Merger  Agreement  as set forth
herein:

                               A G R E E M E N T:

     NOW,  THEREFORE,  in  consideration of the foregoing  premises,  the terms,
conditions and other  covenants and agreements  contained  herein and other good
and  valuable  consideration,  the receipt and  sufficiency  of which are hereby
acknowledged, the parties hereto agree as follows:

     1. Definitions.  As used in the Merger Agreement,  (a) the term "Agreement"
shall mean the initial Merger  Agreement among the parties  hereto,  dated as of
August 23, 1997, and any and all amendments  thereto entered into on or prior to
the date hereof,  and (b) terms defined in the Merger  Agreement and used herein
shall have the meanings given to them in the Merger Agreement.

     2.  Amendment  to  Section  5.2(c)(iv).  Section  5.2(c)(iv)  of the Merger
Agreement is hereby  amended by (i) deleting  the phrase  "Section  6.1(b) to be
satisfied" and substituting  therefor the phrase "Cardinal and Bergen to prevail
in any litigation  involving an HSR Authority" and (ii) deleting the date "April
30, 1998" therein and substituting therefor the date "June 30, 1998."

     3.  Amendment  to  Section  5.3(c)(v).  Section  5.3(c)(v)  of  the  Merger
Agreement is hereby  amended by (i) deleting  the phrase  "Section  6.1(b) to be
satisfied" and substituting  therefor the phrase "Cardinal and Bergen to prevail
in any litigation  involving an HSR Authority" and (ii) deleting the date "April
30, 1998" therein and substituting therefor the date "June 30, 1998."

     4. Amendment to Section 7.1(c).  Section 7.1(c) of the Merger  Agreement is
hereby  amended by  deleting  the  reference  to "April 30,  1998"  therein  and
substituting therefor "June 30, 1998."

     5. Waiver of Termination Right pursuant to Section 7.1(l). Neither Cardinal
nor  Bergen  shall be able to  exercise  their  right to  terminate  the  Merger
Agreement pursuant to Section 7.1(l) and such right to terminate shall have been
deemed to have been waived by each of the parties  hereto upon execution of this
Amendment.

     6. New  Termination  Right upon Entry of  Preliminary  Injunction.  Section
7.1(l) of the Merger  Agreement is hereby  amended by deleting the period at the
end of such subsection and substituting therefor "; or" and a new Section 7.1(m)
shall be added  immediately  following  Section 7.1(l) and immediately  prior to
Section 7.2, which new Section 7.1(m) shall provide as follows:

          (m) by Cardinal or Bergen on one business  day's prior  notice  (which
     notice  must be  received  no  later  than  5:00 pm (New  York  time) to be
     effective the following business day), following the entry of a preliminary
     injunction  by a federal  district  court in  litigation  brought by an HSR
     Authority (but not as a result of a temporary restraining order or a stay),
     which injunction enjoins Cardinal or Bergen from consummating the Merger.

     7.  Expense  Reimbursement.  Section 7.2 of the Merger  Agreement is hereby
amended by adding a new Section 7.2 (c) immediately following Section 7.2(b) and
immediately  prior to Section 7.3,  which new Section  7.2(c)  shall  provide as
follows:

          (c) Cardinal agrees that in the event of termination of this Agreement
     pursuant to (x) Section 7.1 (a), Section 7.1(b) or Section 7.1(c),  in each
     case following the entry of a preliminary  injunction by a federal district
     court in litigation  brought by an HSR Authority (but not in the context of
     a temporary restraining order or a stay), which injunction enjoins Cardinal
     or Bergen  from  consummating  the  Merger,  or (y)  Section  7.1(m),  then
     Cardinal shall pay Bergen $7 million in reimbursement of Bergen's  expenses
     in connection  with the proposed Merger within five business days following
     the date of any such termination.

     8.  No  Other  Amendments.   Except  as  expressly  amended,  modified  and
supplemented in this Amendment,  the parties hereto  acknowledge that the Merger
Agreement  shall remain  binding upon them and that all provisions of the Merger
Agreement  are and shall  remain in full force and effect.  Except as  expressly
provided in this Amendment,  the execution,  delivery and  effectiveness of this
Amendment  shall not  operate as a waiver of any  right,  power or remedy by the
parties hereto,  nor shall it constitute a waiver of any provision in the Merger
Agreement.

     9.  Counterparts.   This  Amendment  may  be  executed  in  any  number  of
counterparts,  each of which  shall be an  original,  but all of which  together
shall constitute one instrument.



<PAGE>


     IN WITNESS WHEREOF, Cardinal, Subcorp and Bergen have signed this Amendment
as of the date first written above.


                              CARDINAL HEALTH, INC.



                              By:     /s/ Robert D. Walter
                                      ________________________
                              Name:   Robert D. Walter
                              Title:  Chairman and Chief Executive Officer



                               BRUIN MERGER CORP.



                             By:     /s/ Robert D. Walter
                                     _________________________
                             Name:   Robert D. Walter
                             Title:  Chairman



                             BERGEN BRUNSWIG CORPORPORATION



                             By:    /s/ Donald R. Roden
                                    __________________________
                             Name:  Donald R. Roden
                             Title: Chief Executive Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission